Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Operating Expenses

$36.28B

TTM · Period ending: Jun 30, 2026 · USD

AZN Operating Expenses

Latest reported$36.28Bperiod endingJun 30, 2026

Latest reported$36.28Bperiod endingJun 30, 2026

AZN TTM Operating Expenses ($6.57B → $36.28B)

TTM operating expenses

High-resolution chart · PNG

AZN operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	11,426,596,924
Mar 31, 2001	11,367,586,461
Dec 31, 2000	11,411,218,241
Sep 30, 2000	11,179,596,673
Jun 30, 2000	11,396,751,472
Mar 31, 2000	11,713,761,935
Dec 31, 1999	14,310,744,402
Sep 30, 1999	10,831,887,218
Jun 30, 1999	11,044,087,218
Mar 31, 1999	10,419,087,218
Dec 31, 1998	8,315,087,218
Sep 30, 1998	8,715,759,340
Jun 30, 1998	8,484,959,340
Mar 31, 1998	9,088,959,340
Dec 31, 1997	8,955,459,340
Sep 30, 1997	11,224,462,756
Jun 30, 1997	11,438,662,756
Mar 31, 1997	11,433,162,756
Dec 31, 1996	11,427,662,756
Sep 30, 1996	8,634,152,932
Jun 30, 1996	8,255,552,932
Mar 31, 1996	6,667,452,932
Dec 31, 1995	6,406,052,932
Sep 30, 1995	6,469,149,215
Jun 30, 1995	6,286,949,215
Mar 31, 1995	7,433,349,215
Dec 31, 1994	7,253,049,215
Sep 30, 1994	6,960,058,718
Jun 30, 1994	6,744,258,718
Mar 31, 1994	6,655,958,718
Dec 31, 1993	6,567,658,718

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.